Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. THRM
THRM logo

THRM Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
28.420
Open
27.530
VWAP
27.78
Vol
228.70K
Mkt Cap
850.82M
Low
27.170
Amount
6.35M
EV/EBITDA(TTM)
5.83
Total Shares
30.65M
EV
879.06M
EV/OCF(TTM)
7.53
P/S(TTM)
0.57
Gentherm Incorporated is a provider of thermal management and pneumatic comfort technologies. The Company operates in two segments: Automotive and Medical. The Automotive reporting segment comprises global automotive businesses, including the design, development, manufacturing and sales of its automotive climate and comfort solutions (including Climate Control Seats, Climate Control Interiors, lumbar and massage comfort solutions and electronic solutions for climate and comfort technologies), valve system solutions and other automotive products. The Medical reporting segment comprises the patient temperature management business in the medical industry. Patient temperature management includes temperature management systems across multiple product categories addressing the needs of hyper-hypothermia therapy in intensive care, normothermia in surgical procedures and additional warming/cooling therapies utilized in acute and chronic care departments and non-hospital facilities.
Show More

Events Timeline

(ET)
2026-03-19
10:20:00
Gentherm Officially Launches New Product with KUKA Home in Asia
select
2026-02-19 (ET)
2026-02-19
06:20:00
Gentherm Sees FY27 Product Revenue About $1.7B
select
2026-02-19
06:20:00
Sees FY26 Adjusted EBITDA of $175M-$195M
select
2026-02-19
06:10:00
Gentherm Q4 Revenue of $382.79M Beats Expectations
select
2026-02-03 (ET)
2026-02-03
08:40:00
Gentherm Submits 510(k) Filing for ThermAffyx to FDA
select

News

Newsfilter
5.0
03-10Newsfilter
Gentherm Partners with KNB to Launch Innovative Medical Device
  • Strategic Partnership Announced: Gentherm has partnered with KNB Communications, which will serve as the official PR agency for Gentherm's medical division, leveraging its expertise to support the launch of the ThermAffyx™ Patient Safety System aimed at enhancing patient safety during surgeries.
  • Innovative Product Introduction: The ThermAffyx™ Patient Safety System is the first medical device designed to integrate patient warming and securement, addressing dual challenges faced during surgeries, which is expected to significantly improve patient experience and safety in surgical settings.
  • FDA Application Progress: Gentherm submitted a 510(k) Class II premarket notification to the FDA for the ThermAffyx™ earlier this year, with clearance anticipated in May, paving the way for market entry and enhancing competitive positioning.
  • Significant Market Potential: Gentherm recorded approximately $1.5 billion in annual sales in 2024 and secured $2.4 billion in new automotive business awards, indicating strong growth potential and strategic importance in expanding its footprint in the medical device market, particularly in innovations related to patient safety.
PRnewswire
5.0
03-10PRnewswire
Gentherm Partners with KNB to Launch Innovative Medical Device
  • Strategic Partnership Announced: Gentherm has partnered with KNB Communications, which will serve as the official PR agency for Gentherm's medical division, leveraging its expertise to support the launch of the ThermAffyx™ Patient Safety System aimed at enhancing patient safety during surgeries.
  • Innovative Medical Device: The ThermAffyx™ Patient Safety System is the first medical device designed to integrate patient warming and securement challenges into a single solution, addressing a critical clinical need and expected to significantly improve patient safety during surgical procedures.
  • FDA Application Progress: Gentherm submitted a 510(k) Class II premarket notification for ThermAffyx™ to the FDA earlier this year, with clearance anticipated in May, paving the way for the product's market introduction.
  • Significant Market Potential: Gentherm recorded approximately $1.5 billion in annual sales in 2024 and secured $2.4 billion in new automotive business awards, highlighting its strong potential and growth prospects in the medical device market.
Benzinga
6.0
02-24Benzinga
Wall Street Analysts Adjust Ratings on Key Stocks
  • Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several stocks, including upgrades, downgrades, and initiations, reflecting varying market perspectives that could influence investor decisions.
  • Market Dynamics: As analysts revise their outlook on THRM stock, investors may consider buying or selling, potentially impacting its market performance and liquidity, thereby increasing market uncertainty.
  • Impact of Rating Changes: Changes in analyst ratings often have a direct effect on stock prices, prompting investors to closely monitor these shifts to timely adjust their investment strategies and optimize their portfolios.
  • Source of Information: This information is provided by Benzinga, highlighting the significance of analyst ratings in investment decisions, and investors should reference these ratings for a more comprehensive market view.
seekingalpha
9.5
02-19seekingalpha
Gentherm Q4 2025 Earnings Call Insights
  • Strategic Expansion: Gentherm's planned merger with Modine Performance Technologies is expected to elevate its market size from $2.6 billion to over $3.5 billion, showcasing the company's strong potential for diversification, particularly in the medical and Home & Office sectors.
  • Financial Performance: The company achieved record revenue of $1.5 billion in 2025, reflecting a 2.9% year-over-year increase, with adjusted EBITDA of $175 million, or 11.7% of sales, demonstrating stability in core operations despite foreign exchange impacts.
  • Future Outlook: Management anticipates revenue for 2026 to be between $1.5 billion and $1.6 billion, representing approximately 3% growth at the midpoint, and aims for $1.7 billion in 2027, reflecting confidence in market penetration.
  • Market Opportunities: Gentherm expects revenue from Home & Office and medical markets to reach between $50 million and $100 million by 2028, indicating significant growth potential in non-automotive sectors, particularly with the launch of the ThermAffyx system to accelerate medical revenue growth.
Benzinga
6.0
02-19Benzinga
Wall Street Analysts Adjust Ratings on Key Stocks
  • Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several stocks, including upgrades, downgrades, and initiations, reflecting varying market perspectives on these companies.
  • Market Reaction: While specific stocks are not mentioned, such rating changes typically influence investor decisions and may lead to price volatility in the affected stocks.
  • Investor Focus: Investors considering buying CAKE stock should pay attention to the latest insights from analysts to make more informed investment decisions.
  • Information Source: A complete view of all analyst rating changes can be found on Benzinga's analyst ratings page, providing comprehensive market insights and data support.
Benzinga
6.5
02-19Benzinga
Wall Street Analysts Adjust Ratings on Key Stocks
  • Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several stocks, including upgrades, downgrades, and initiations, reflecting varying market perspectives and future expectations for these companies.
  • Market Dynamics: While specific stock names are not disclosed, changes in analyst ratings typically influence investor decisions and can lead to price volatility in the affected stocks.
  • Investor Focus: Investors considering buying TEM stock should pay attention to the latest insights from analysts to make more informed investment decisions, especially amid increasing market uncertainties.
  • Source of Information: This information is provided by Benzinga, highlighting the significance of analyst ratings in investment decisions, despite the lack of specific rating details.
Wall Street analysts forecast THRM stock price to rise
4 Analyst Rating
Wall Street analysts forecast THRM stock price to rise
2 Buy
2 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
42.00
Averages
43.33
High
44.00
Current: 0.000
sliders
Low
42.00
Averages
43.33
High
44.00
Roth Capital
Buy
downgrade
$44 -> $39
AI Analysis
2026-03-23
Reason
Roth Capital
Price Target
$44 -> $39
AI Analysis
2026-03-23
downgrade
Buy
Reason
Roth Capital lowered the firm's price target on Gentherm to $39 from $44 and keeps a Buy rating on the shares. The firm anticipates the company's sales and adjusted EBITDA to come in below the midpoint of 2026 guidance, the analyst tells investors in a research note. Roth remains positive on Gentherm's adjacent market growth traction and an improving margin set up into 2027 but also notes the recent macro disruption that could keep the stock range-bound while investors await clarity, the firm added.
Freedom Capital
Dmitriy Pozdnyakov
Buy
to
Hold
downgrade
$41 -> $38
2026-02-25
Reason
Freedom Capital
Dmitriy Pozdnyakov
Price Target
$41 -> $38
2026-02-25
downgrade
Buy
to
Hold
Reason
Freedom Capital analyst Dmitriy Pozdnyakov downgraded Gentherm to Hold from Buy with a price target of $38, down from $41. Gentherm posted a "mixed" Q4 while noting footprint actions will pressure margins through 2026, the analyst tells investors in a post-earnings note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for THRM
Unlock Now

Valuation Metrics

The current forward P/E ratio for Gentherm Inc (THRM.O) is 10.76, compared to its 5-year average forward P/E of 22.24. For a more detailed relative valuation and DCF analysis to assess Gentherm Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
22.24
Current PE
10.76
Overvalued PE
32.49
Undervalued PE
11.99

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
10.90
Current EV/EBITDA
5.86
Overvalued EV/EBITDA
15.60
Undervalued EV/EBITDA
6.20

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.33
Current PS
0.51
Overvalued PS
1.95
Undervalued PS
0.72

Financials

AI Analysis
Annual
Quarterly

Whales Holding THRM

G
Global Alpha Capital Management Ltd.
Holding
THRM
-2.89%
3M Return
S
Segall Bryant & Hamill, LLC
Holding
THRM
-2.94%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Gentherm Inc (THRM) stock price today?

The current price of THRM is 27.76 USD — it has decreased -1.77

What is Gentherm Inc (THRM)'s business?

Gentherm Incorporated is a provider of thermal management and pneumatic comfort technologies. The Company operates in two segments: Automotive and Medical. The Automotive reporting segment comprises global automotive businesses, including the design, development, manufacturing and sales of its automotive climate and comfort solutions (including Climate Control Seats, Climate Control Interiors, lumbar and massage comfort solutions and electronic solutions for climate and comfort technologies), valve system solutions and other automotive products. The Medical reporting segment comprises the patient temperature management business in the medical industry. Patient temperature management includes temperature management systems across multiple product categories addressing the needs of hyper-hypothermia therapy in intensive care, normothermia in surgical procedures and additional warming/cooling therapies utilized in acute and chronic care departments and non-hospital facilities.

What is the price predicton of THRM Stock?

Wall Street analysts forecast THRM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for THRM is43.33 USD with a low forecast of 42.00 USD and a high forecast of 44.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Gentherm Inc (THRM)'s revenue for the last quarter?

Gentherm Inc revenue for the last quarter amounts to 382.79M USD, increased 8.46

What is Gentherm Inc (THRM)'s earnings per share (EPS) for the last quarter?

Gentherm Inc. EPS for the last quarter amounts to 0.10 USD, decreased -79.59

How many employees does Gentherm Inc (THRM). have?

Gentherm Inc (THRM) has 14174 emplpoyees as of April 05 2026.

What is Gentherm Inc (THRM) market cap?

Today THRM has the market capitalization of 850.82M USD.